Optimizing Self-management COPD Treatment Through the American Lung Association Helpline
Status
Conditions
Treatments
Details and patient eligibility
About
Although self-management treatment improves quality of life among individuals with COPD, there is limited understanding of which elements of treatment are most effective. The proposed research will test the feasibility of using an engineering-inspired study design to identify effective COPD self-management treatment components. The long-term goal of this line of research is to optimize the effectiveness of COPD self-management treatment, and improve quality of life for individuals with COPD.
Full description
Chronic Obstructive Pulmonary Disease (COPD) is an increasingly prevalent and costly chronic health condition, and is the third major cause of morbidity and mortality in the United States. Self-management treatment programs for COPD are shown to improve health-related quality of life and prevent COPD-related hospitalizations. Despite their clinical benefits, these programs are typically multi-component and time- and resource-intensive. To date, no study has been conducted to isolate the role of individual self-management treatment components in contributing to improved COPD outcomes. The proposed research will establish the feasibility of using the Multiphase Optimization Strategy (MOST) framework to optimize COPD self-management treatment delivered by the American Lung Association (ALA) Helpline. Treatment components to be evaluated include duration of self-management education, ground-based walking training, inhaler training, and caregiver support. The primary outcome is health-related quality of life, with secondary outcomes of COPD symptom burden, self-management behaviors, and hospitalization. Specific aims are:
Aim 1: Design a factorial experiment and develop operational procedures. The investigators will design a factorial experiment with the same number of experimental conditions and length of follow-up as the planned optimization trial. In collaboration with the ALA COPD Helpline, the investigators will develop operational procedures (i.e., recruitment, screening, randomization, and database management) for successful implementation.
Aim 2: Establish feasibility and acceptability by pilot testing the study design. The investigators will deliver treatment to three participants per experimental condition (N=48) with good fidelity, and will remotely assess baseline, mediator, and outcome variables. The investigators will conduct qualitative interviews at end-of-treatment with 15-20 participants. Resulting values will provide estimates of recruitment and retention rates, treatment fidelity, acceptability of treatment components, and outcome measure variability to inform a subsequent, fully-powered optimization trial. The primary outcome is health-related quality of life, with secondary outcomes of COPD symptom burden, self-management behaviors, and hospitalization.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Eligible participants will be males and females who are:
- 40 years or older,
- report a physician diagnosis of COPD,
- use an inhaler for COPD at least once a week,
- able to walk at least one block without assistance,
- able to identify a caregiver, and
- have access to a connected device (i.e., smart phone, tablet, and/ or computer).
Exclusion criteria
- cognitive dysfunction impairing ability to provide informed consent and follow study procedures,
- terminal illness (i.e. less than 6 months life expectancy) that is non-COPD related,
- living at a chronic care facility (i.e. nursing home, assisted living), or
- inability to speak and read English.
Trial design
Primary purpose
Allocation
Interventional model
Masking
46 participants in 16 patient groups
Trial contacts and locations
Loading...
Central trial contact
Maritza Esqueda-Medina; Amanda R Mathew, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal